A Randomized, Open-label, Parallel-group, Active-control PK/PD Study of Three Doses of Leuprolide Oral Tablets in Comparison to an IM Dose of Leuprolide in Healthy Female Volunteers

Trial Profile

A Randomized, Open-label, Parallel-group, Active-control PK/PD Study of Three Doses of Leuprolide Oral Tablets in Comparison to an IM Dose of Leuprolide in Healthy Female Volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Jun 2018

At a glance

  • Drugs Leuprorelin (Primary) ; Leuprorelin
  • Indications Endometriosis
  • Focus Pharmacodynamics
  • Sponsors Enteris BioPharma
  • Most Recent Events

    • 26 Jun 2018 According to an Enteris BioPharma media release,company announced positive results fro this trial
    • 18 Jun 2018 Status changed from active, no longer recruiting to completed.
    • 30 Apr 2018 According to an Enteris BioPharma media release, Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top